Science
Advanced obesity research services now play a critical role within metabolic disease drug discovery due to rising global incidence and increasing therapeutic demand. Researchers across biotech and pharmaceutical sectors often investigate adipose dysfunction, chronic inflammation, insulin resistance, and lipid metabolism during early-stage programme development.